– USA, ND – Noridian Healthcare Solutions, LLC, a leader in developing health care administrative solutions, announced the appointment of Jonathan Blum to its board of directors.
About Jonathan Blum
Jonathan Blum is a respected health care policy expert and a former principal deputy administrator and COO at the Centers for Medicare & Medicaid Services.
His tenure at CMS included close coordination with the White House to lead the CMS response during the height of the COVID-19 pandemic, the development of preparation materials for future pandemics, and other disaster responses. Over time, he led the agency’s efforts to unwind policy and operational responses implemented during the pandemic.
Further, he oversaw all aspects of CMS’ $1.5 trillion program budget and $11 billion operating budget. Setting a priority to drive the strategy to reduce and reform CMS’ contractor and IT spending, producing an operating surplus for FY 2025.
Jonathan Blum is a senior scholar at the USC Schaeffer Institute. He holds a master’s in public policy from the John F. Kennedy School of Government at Harvard University and a Bachelor of Arts from the University of Pennsylvania.
About Noridian Healthcare Solutions
Noridian Healthcare Solutions, LLC, develops solutions for healthcare programs through a full suite of innovative offerings, including claims processing, medical review, and contact center and provider administrative services. Headquartered in Fargo, North Dakota, with staff located throughout the nation, Noridian administers people-first services across all 50 U.S. states. Leveraging its decades of experience, the Noridian team designs and implements high-quality, customizable solutions to eliminate common healthcare barriers, enabling access to care.
For more information: https://noridiansolutions.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.